In a recent 8-K filing with the SEC, Tenaya Therapeutics, Inc. announced the appointment of Mr. Tomohiro Higa as the Interim Principal Accounting Officer (PAO), effective Thursday. Mr. Higa ...

Spire Wealth Management bought a new position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC.

Shares of TNYA stock opened at $1.04 on Monday. The company has a market cap of $82.39 million, a P/E ratio of -0.72 and a beta of 2.84. The business has a 50 day moving average of $1.88 and a two ...

Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies ...

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report). The company’s shares opened today at $1.42. According to TipRanks ...

Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that ...